Promote flu vaccinations among Almaty residents, Nadirov advises
Here's the rewritten article:
Vaxin' Ain't Optional, Says Almaty's Health Chief — Particularly Crucial During This Pandemic
Kamaljan Nadyrov, Almaty's Public Health Department boss, has made it clear: vaccination is a bloody must this year, especially during the pandemic, according to Almaty.tv, citing the city akimat press service. The reason? A potential overlap of COVID-19 with other diseases, which could make things real gruesome.
Now, Nadyrov ain't mincing his words. He's urging Almaty residents to not ignore the call to get vaxxed, to help beat the flu and cold during this pandemic and the high season of diseases. He assured that the vaccine used is safe and has been proven effective in previous years.
So, where did all this dough come from? The local budget, mate. They've set aside enough cash to buy 130,000 doses of the trivalent anti-flu vaccine "Grippol Plus" for free vaccinations of at-risk groups. By October, an extra 300,000 doses are expected to drop, taking into account the COVID-19 situation.
Now, you might be wondering, why the early start this year? 'Cause of the pandemic, of course. The vaxin' period kicked off earlier and'll continue until early December.
As for the trivalent anti-flu vaccine "Grippol Plus," there isn't much info about its effectiveness and safety during the pandemic. A search through various sources didn't reveal any specific data. So, if you're curious about the vaccine, best to let health organizations or scientific databases be your guides.
[1] Based on available search results, there's no specific data on the effectiveness and safety of the trivalent anti-flu vaccine "Grippol Plus" during the COVID-19 pandemic. However, research does provide general info on vaccine adjuvants like BCG-Polysaccharide Nucleic Acid (BCG-PSN) that boost vaccine efficiency, but it doesn't relate directly to "Grippol Plus" or its performance during the pandemic. For detailed info on "Grippol Plus," it's recommended to consult specific studies or data related to this vaccine, possibly through health organizations or scientific databases.
[1] Although general information on vaccine adjuvants like BCG-Polysaccharide Nucleic Acid (BCG-PSN) exists, which boost vaccine efficiency, there is no specific data on the effectiveness and safety of the trivalent anti-flu vaccine "Grippol Plus" during the COVID-19 pandemic.
[2] Residents of Almaty are encouraged to consult health organizations or scientific databases for detailed information about "Grippol Plus" and its performance during the pandemic.
[3] The local budget in Almaty has allocated funds to purchase 130,000 doses of the trivalent anti-flu vaccine "Grippol Plus" for free vaccinations of at-risk groups.
[4] An additional 300,000 doses of the vaccine are expected to become available by October, taking into account the COVID-19 situation.
